デフォルト表紙
市場調査レポート
商品コード
1322266

ベンゾジアゼピンAPI市場:世界の業界分析、規模、シェア、成長、動向、および予測、2023年から2031年

Benzodiazepine APIs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版日: | 発行: Transparency Market Research | ページ情報: 英文 244 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.94円
ベンゾジアゼピンAPI市場:世界の業界分析、規模、シェア、成長、動向、および予測、2023年から2031年
出版日: 2023年06月20日
発行: Transparency Market Research
ページ情報: 英文 244 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ベンゾジアゼピンAPI市場- レポートの範囲

世界のベンゾジアゼピンAPI市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。 このレポートでは、2023年を基準年、2031年を予測年として、2017年から2031年までのベンゾジアゼピンAPIの世界市場の収益を掲載しています。また、2023年から2031年までの世界のベンゾジアゼピンAPI市場の複合年間成長率(CAGR %)も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、ベンゾジアゼピンAPI市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

このレポートは、世界のベンゾジアゼピンAPI市場の競合情勢を詳しく掘り下げています。世界のベンゾジアゼピンAPI市場で活動している主要プレーヤーが特定され、これらのそれぞれがさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界のベンゾジアゼピンAPI市場のプレーヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場の分析と予測、2017~2031年

第5章 主要な洞察

  • ベンゾジアゼピンの適用概要
  • 中国と米国におけるベンゾジアゼピンの規制シナリオ
  • 欧州におけるクロナゼパム市場トップ 3
  • COVID-19パンデミックによる業界への影響(バリューチェーンと短期・中期・長期的な影響)

第6章 世界市場の分析と予測:製品別

  • イントロダクションと定義
  • 主な発見と開発
  • 市場金額予測:製品別、2017年~2031年
    • アルプラゾラム
    • ブロマゼパム
    • クロルジアゼポキシド
    • クロバザム
    • クロナゼパム
    • クロラゼプト
    • ジアゼパム
    • ロラゼパム
    • ミダゾラム
    • ニトラゼパム
    • オキサゼパム
    • テマゼパム
    • その他
  • 市場の魅力度:製品別

第7章 世界市場の分析と予測:活動時期別

  • イントロダクションと定義
  • 主な発見と開発
  • 市場金額予測:活動時期別、2017-2031
    • 短時間作用型
    • 中級
    • 長時間作用型
  • 市場の魅力度:活動時期別

第8章 世界市場の分析と予測:エンドユーザー別

  • イントロダクションと定義
  • 主な発見と開発
  • 市場金額予測:エンドユーザー別、2017年~2031年
    • 製薬およびバイオテクノロジー産業
    • CMO
    • その他(調査機関等)
  • 市場の魅力度:エンドユーザー別

第9章 世界市場の分析と予測:地域別

  • 主な調査結果
  • 市場金額予測:地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力度:国・地域別

第10章 北米市場の分析と予測

第11章 欧州市場の分析と予測

第12章 アジア太平洋市場の分析と予測

第13章 ラテンアメリカ市場の分析と予測

第14章 中東およびアフリカ市場の分析と予測

第15章 競合情勢

  • 市場参入企業- 競合マトリックス(企業の階層および規模別)
  • 市場シェア分析:企業別(2022年)
  • 企業プロファイル
    • Sun Pharmaceutical Industries Ltd.
    • Merck KGaA
    • LGC GmbH(LGC Science Group Holdings Limited)
    • Nortec Quimica SA
    • Centaur Pharmaceuticals
    • Eisai Co., Ltd
    • Global Calcium PVT LTD
    • Delphis Pharma
    • Mylan NV(Viatris Inc.)
    • Taj Pharmaceuticals Ltd.
図表

List of Tables

  • Table 01: Global Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 03: Global Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 06: North America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 07: North America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 08: North America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 09: U.S. Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 10: U.S. Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 11: U.S. Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 12: Canada Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 13: Canada Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 14: Canada Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 15: Europe Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 16: Europe Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 17: Europe Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 18: Europe Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 19: Germany Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 20: Germany Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 21: Germany Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 22: U.K. Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 23: U.K. Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 24: U.K. Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 25: France Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 26: France Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 27: France Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 28: Italy Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 29: Italy Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 30: Italy Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 31: Spain Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 32: Spain Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 33: Spain Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 34: Rest of Europe Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 35: Rest of Europe Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 36: Rest of Europe Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 37: Asia Pacific Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 38: Asia Pacific Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 39: Asia Pacific Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 40: Asia Pacific Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Country/Sub-region , 2017-2031
  • Table 41: Japan Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 42: Japan Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 43: Japan Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 44: China Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 45: China Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 46: China Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 47: India Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 48: India Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 49: India Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 50: Australia & New Zealand Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 51: Australia & New Zealand Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 52: Australia & New Zealand Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 53: Rest of Asia Pacific Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 54: Rest of Asia Pacific Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 55: Rest of Asia Pacific Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 56: Latin America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 57: Latin America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 58: Latin America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 59: Latin America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 60: Brazil Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 61: Brazil Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 62: Brazil Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 63: Mexico Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 64: Mexico Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 65: Mexico Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 66: Rest of Latin America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 67: Rest of Latin America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 68: Rest of Latin America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 69: Middle East & Africa Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 70: Middle East & Africa Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 71: Middle East & Africa Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 72: Middle East & Africa Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 73: GCC Countries Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 74: GCC Countries Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 75: GCC Countries Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 76: South Africa Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 77: South Africa Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 78: South Africa Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 79: Rest of MEA Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 80: Rest of MEA Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 81: Rest of MEA Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Benzodiazepine API Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Benzodiazepine APIs Market Attractiveness Analysis, by Product 2023-2031
  • Figure 03: Global Benzodiazepine APIs Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 04: Global Benzodiazepine APIs Market Value (US$ Mn), by Alprazolam, 2017-2031
  • Figure 05: Global Benzodiazepine APIs Market Value (US$ Mn), by Bromazepam, 2017-2031
  • Figure 06: Global Benzodiazepine APIs Market Value (US$ Mn), by Irreversible Chlordiazepoxide, 2017-2031
  • Figure 07: Global Benzodiazepine APIs Market Value (US$ Mn), by Clobazam, 2017-2031
  • Figure 08: Global Benzodiazepine APIs Market Value (US$ Mn), by Clonazepam, 2017-2031
  • Figure 09: Global Benzodiazepine APIs Market Value (US$ Mn), by Clorazepate, 2017-2031
  • Figure 10: Global Benzodiazepine APIs Market Value (US$ Mn), by Diazepam, 2017-2031
  • Figure 11: Global Benzodiazepine APIs Market Value (US$ Mn), by Lorazepam, 2017-2031
  • Figure 12: Global Benzodiazepine APIs Market Value (US$ Mn), by Midazolam, 2017-2031
  • Figure 13: Global Benzodiazepine APIs Market Value (US$ Mn), by Nitrazepam, 2017-2031
  • Figure 14: Global Benzodiazepine APIs Market Value (US$ Mn), by Oxazepam, 2017-2031
  • Figure 15: Global Benzodiazepine APIs Market Value (US$ Mn), by Temazepam, 2017-2031
  • Figure 16: Global Benzodiazepine APIs Market Value (US$ Mn), by Others, 2017-2031
  • Figure 17: Global Benzodiazepine APIs Market Value Share Analysis, by Time of Action, 2022 and 2031
  • Figure 18: Global Benzodiazepine APIs Market Attractiveness Analysis, Time of Action, 2023-2031
  • Figure 19: Global Benzodiazepine APIs Market Revenue (US$ Mn), by Short Acting, 2017-2031
  • Figure 20: Global Benzodiazepine APIs Market Revenue (US$ Mn), by Intermediate, 2017-2031
  • Figure 21: Global Benzodiazepine APIs Market Revenue (US$ Mn), by Long Acting, 2017-2031
  • Figure 22: Global Benzodiazepine APIs Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 23: Global Benzodiazepine APIs Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 24 Global Benzodiazepine APIs Market Revenue (US$ Mn), by Pharmaceutical & Biotechnology Industries, 2017-2031
  • Figure 25: Global Benzodiazepine APIs Market Revenue (US$ Mn), by CMOs, 2017-2031
  • Figure 26: Global Benzodiazepine APIs Market Revenue (US$ Mn), Others, 2017-2031
  • Figure 27: Global Benzodiazepine APIs Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 28: Global Benzodiazepine APIs Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 29: North America Benzodiazepine APIs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 30: North America Benzodiazepine APIs Market Attractiveness Analysis, by Product, 2022 and 2031
  • Figure 31: North America Benzodiazepine APIs Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 32: North America Benzodiazepine APIs Market Value Share Analysis, by Time of Action, 2022 and 2031
  • Figure 33: North America Benzodiazepine APIs Market Attractiveness Analysis, Time of Action, 2023-2031
  • Figure 34: North America Benzodiazepine APIs Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 35: North America Benzodiazepine APIs Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 36: North America Benzodiazepine APIs Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 37: North America Benzodiazepine APIs Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 38: Europe Benzodiazepine APIs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 39: Europe Benzodiazepine APIs Market Attractiveness Analysis, by Product 2023-2031
  • Figure 40: Europe Benzodiazepine APIs Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 41: Europe Benzodiazepine APIs Market Value Share Analysis, by Time of Action, 2022 and 2031
  • Figure 42: Europe Benzodiazepine APIs Market Attractiveness Analysis, Time of Action, 2023-2031
  • Figure 43: Europe Benzodiazepine APIs Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 44: Europe Benzodiazepine APIs Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 45: Europe Benzodiazepine APIs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 46: Europe Benzodiazepine APIs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 47: Asia Pacific Benzodiazepine APIs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 48: Asia Pacific Benzodiazepine APIs Market Attractiveness Analysis, by Product 2023-2031
  • Figure 49: Asia Pacific Benzodiazepine APIs Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 50: Asia Pacific Benzodiazepine APIs Market Value Share Analysis, by Time of Action, 2022 and 2031
  • Figure 51: Asia Pacific Benzodiazepine APIs Market Attractiveness Analysis, Time of Action, 2023-2031
  • Figure 52: Asia Pacific Benzodiazepine APIs Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 53: Asia Pacific Benzodiazepine APIs Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 54: Asia Pacific Benzodiazepine APIs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 55: Asia Pacific Benzodiazepine APIs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 56: Latin America Benzodiazepine APIs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 57: Latin America Benzodiazepine APIs Market Attractiveness Analysis, by Product 2023-2031
  • Figure 58: Latin America Benzodiazepine APIs Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 59: Latin America Benzodiazepine APIs Market Value Share Analysis, by Time of Action, 2022 and 2031
  • Figure 60: Latin America Benzodiazepine APIs Market Attractiveness Analysis, Time of Action, 2023-2031
  • Figure 61: Latin America Benzodiazepine APIs Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 62: Latin America Benzodiazepine APIs Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 63: Latin America Benzodiazepine APIs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 64: Latin America Benzodiazepine APIs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 65: Middle East & Africa Benzodiazepine APIs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 66: Middle East & Africa Benzodiazepine APIs Market Attractiveness Analysis, by Product 2023-2031
  • Figure 67: Middle East & Africa Benzodiazepine APIs Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 68: Middle East & Africa Benzodiazepine APIs Market Value Share Analysis, by Time of Action, 2022 and 2031
  • Figure 69: Middle East & Africa Benzodiazepine APIs Market Attractiveness Analysis, Time of Action, 2023-2031
  • Figure 70: Middle East & Africa Benzodiazepine APIs Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 71: Middle East & Africa Benzodiazepine APIs Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 72: Middle East & Africa Benzodiazepine APIs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 73: Middle East & Africa Benzodiazepine APIs Market Attractiveness Analysis, by Country/Sub-region , 2023-2031
目次
Product Code: TMRGL85671

Benzodiazepine APIs Market - Scope of Report

TMR's report on the global Benzodiazepine APIs Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Benzodiazepine APIs Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Benzodiazepine APIs Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Benzodiazepine APIs Market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Benzodiazepine APIs Market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Benzodiazepine APIs Market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Benzodiazepine APIs Market.

The report delves into the competitive landscape of the global Benzodiazepine APIs Market. Key players operating in the global Benzodiazepine APIs Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Benzodiazepine APIs Market profiled in this report.

Key Questions Answered in Global Benzodiazepine APIs Market Report:

  • What is the sales/revenue generated by mobile photo printer across all regions during the forecast period?
  • What are the opportunities in the global Benzodiazepine APIs Market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Benzodiazepine APIs Market - Research Objectives and Research Approach

The comprehensive report on the global Benzodiazepine APIs Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Benzodiazepine APIs Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Benzodiazepine APIs.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Benzodiazepine APIs Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Benzodiazepine APIs Market Analysis and Forecast, 2017 - 2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Benzodiazepine Application Overview
  • 5.2. Regulatory Scenario for Benzodiazepines in China and U.S.
  • 5.3. Top 3 Markets for Clonazepam in Europe
  • 5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long Term impact)

6. Global Benzodiazepine APIs Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product, 2017 - 2031
    • 6.3.1. Alprazolam
    • 6.3.2. Bromazepam
    • 6.3.3. Chlordiazepoxide
    • 6.3.4. Clobazam
    • 6.3.5. Clonazepam
    • 6.3.6. Clorazepate
    • 6.3.7. Diazepam
    • 6.3.8. Lorazepam
    • 6.3.9. Midazolam
    • 6.3.10. Nitrazepam
    • 6.3.11. Oxazepam
    • 6.3.12. Temazepam
    • 6.3.13. Others
  • 6.4. Market Attractiveness, by Product

7. Global Benzodiazepine APIs Market Analysis and Forecast, by Time of Action

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Time of Action, 2017 - 2031
    • 7.3.1. Short Acting
    • 7.3.2. Intermediate
    • 7.3.3. Long Acting
  • 7.4. Market Attractiveness, by Time of Action

8. Global Benzodiazepine APIs Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by End-user, 2017 - 2031
    • 8.3.1. Pharmaceutical & Biotechnology Industries
    • 8.3.2. CMOs
    • 8.3.3. Others (Research Institutes, etc.)
  • 8.4. Market Attractiveness, by End-user

9. Global Benzodiazepine APIs Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness, by Country/Region

10. North America Benzodiazepine APIs Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2017 - 2031
    • 10.2.1. Alprazolam
    • 10.2.2. Bromazepam
    • 10.2.3. Chlordiazepoxide
    • 10.2.4. Clobazam
    • 10.2.5. Clonazepam
    • 10.2.6. Clorazepate
    • 10.2.7. Diazepam
    • 10.2.8. Lorazepam
    • 10.2.9. Midazolam
    • 10.2.10. Nitrazepam
    • 10.2.11. Oxazepam
    • 10.2.12. Temazepam
    • 10.2.13. Others
  • 10.3. Market Value Forecast, by Time of Action, 2017 - 2031
    • 10.3.1. Short Acting
    • 10.3.2. Intermediate
    • 10.3.3. Long Acting
  • 10.4. Market Value Forecast, by End-user, 2017 - 2031
    • 10.4.1. Pharmaceutical & Biotechnology Industries
    • 10.4.2. CMOs
    • 10.4.3. Others (Research Institutes, etc.)
  • 10.5. Market Value Forecast, by Country, 2017 - 2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product
    • 10.6.2. By Time of Action
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Benzodiazepine APIs Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017 - 2031
    • 11.2.1. Alprazolam
    • 11.2.2. Bromazepam
    • 11.2.3. Chlordiazepoxide
    • 11.2.4. Clobazam
    • 11.2.5. Clonazepam
    • 11.2.6. Clorazepate
    • 11.2.7. Diazepam
    • 11.2.8. Lorazepam
    • 11.2.9. Midazolam
    • 11.2.10. Nitrazepam
    • 11.2.11. Oxazepam
    • 11.2.12. Temazepam
    • 11.2.13. Others
  • 11.3. Market Value Forecast, by Time of Action, 2017 - 2031
    • 11.3.1. Short Acting
    • 11.3.2. Intermediate
    • 11.3.3. Long Acting
  • 11.4. Market Value Forecast, by End-user, 2017 - 2031
    • 11.4.1. Pharmaceutical & Biotechnology Industries
    • 11.4.2. CMOs
    • 11.4.3. Others (Research Institutes, etc.)
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product
    • 11.6.2. By Time of Action
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Benzodiazepine APIs Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017 - 2031
    • 12.2.1. Alprazolam
    • 12.2.2. Bromazepam
    • 12.2.3. Chlordiazepoxide
    • 12.2.4. Clobazam
    • 12.2.5. Clonazepam
    • 12.2.6. Clorazepate
    • 12.2.7. Diazepam
    • 12.2.8. Lorazepam
    • 12.2.9. Midazolam
    • 12.2.10. Nitrazepam
    • 12.2.11. Oxazepam
    • 12.2.12. Temazepam
    • 12.2.13. Others
  • 12.3. Market Value Forecast, by Time of Action, 2017 - 2031
    • 12.3.1. Short Acting
    • 12.3.2. Intermediate
    • 12.3.3. Long Acting
  • 12.4. Market Value Forecast, by End-user, 2017 - 2031
    • 12.4.1. Pharmaceutical & Biotechnology Industries
    • 12.4.2. CMOs
    • 12.4.3. Others (Research Institutes, etc.)
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of APAC
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product
    • 12.6.2. By Time of Action
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Benzodiazepine APIs Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017 - 2031
    • 13.2.1. Alprazolam
    • 13.2.2. Bromazepam
    • 13.2.3. Chlordiazepoxide
    • 13.2.4. Clobazam
    • 13.2.5. Clonazepam
    • 13.2.6. Clorazepate
    • 13.2.7. Diazepam
    • 13.2.8. Lorazepam
    • 13.2.9. Midazolam
    • 13.2.10. Nitrazepam
    • 13.2.11. Oxazepam
    • 13.2.12. Temazepam
    • 13.2.13. Others
  • 13.3. Market Value Forecast, by Time of Action, 2017 - 2031
    • 13.3.1. Short Acting
    • 13.3.2. Intermediate
    • 13.3.3. Long Acting
  • 13.4. Market Value Forecast, by End-user, 2017 - 2031
    • 13.4.1. Pharmaceutical & Biotechnology Industries
    • 13.4.2. CMOs
    • 13.4.3. Others (Research Institutes, etc.)
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product
    • 13.6.2. By Time of Action
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Benzodiazepine APIs Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2017 - 2031
    • 14.2.1. Alprazolam
    • 14.2.2. Bromazepam
    • 14.2.3. Chlordiazepoxide
    • 14.2.4. Clobazam
    • 14.2.5. Clonazepam
    • 14.2.6. Clorazepate
    • 14.2.7. Diazepam
    • 14.2.8. Lorazepam
    • 14.2.9. Midazolam
    • 14.2.10. Nitrazepam
    • 14.2.11. Oxazepam
    • 14.2.12. Temazepam
    • 14.2.13. Others
  • 14.3. Market Value Forecast, by Time of Action, 2017 - 2031
    • 14.3.1. Short Acting
    • 14.3.2. Intermediate
    • 14.3.3. Long Acting
  • 14.4. Market Value Forecast, by End-user, 2017 - 2031
    • 14.4.1. Pharmaceutical & Biotechnology Industries
    • 14.4.2. CMOs
    • 14.4.3. Others (Research Institutes, etc.)
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product
    • 14.6.2. By Time of Action
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. Sun Pharmaceutical Industries Ltd.
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Merck KGaA
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. LGC GmbH (LGC Science Group Holdings Limited)
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Nortec Quimica S.A.
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Centaur Pharmaceuticals
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Eisai Co., Ltd
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Global Calcium PVT LTD
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Delphis Pharma
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Mylan N.V. (Viatris Inc.)
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Taj Pharmaceuticals Ltd.
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Strategic Overview